D. Devos

Overview on wearable sensors for the management of Parkinson’s disease

D. Grabli, M. Béreau, T. Rouaud, 2023, NPJ Parkinson's disease.

Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS

L. Defebvre, A. Destée, D. Devos, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

J. Corvol, J. Kluza, F. Auger, 2014, Antioxidants & redox signaling.

The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.

B. Jarraya, J. Corvol, Anne‐Sophie Rolland, 2024, Journal of neurology.

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

D. Berg, D. Devos, C. Moreau, 2019, Front. Neurol..

Trial of Lixisenatide in Early Parkinson's Disease.

J. Houeto, J. Corvol, F. Ory-Magne, 2024, The New England journal of medicine.